GlassScriptPhysician profile
Alireza Nazeri
NPI 1306025143
$16,944.18
in general payments reported to CMS, 2019-2025
17 companies · $2,655 in 2025
The $2,655 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $232 · 2021: $294 · 2022: $684 · 2023: $6,308 · 2024: $5,973 · 2025: $2,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,847 · Travel and Lodging: $4,905 · Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,847.00 |
| Travel and Lodging | $4,905.11 |
| Food and Beverage | $1,183.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $9,086.04 | 2019-2024 | |
| Abbott Laboratories | $5,327.14 | 2019-2025 | Aveir, Amplatzer Amulet, Gallant |
| Boston Scientific Corporation | $940.32 | 2021-2023 | Bodyguardian, Rhythmia Mapping System, Latitude Communicator Power Supply |
| Medtronic, INC. | $525.82 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $326.25 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $242.92 | 2019-2023 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $117.44 | 2020-2022 | |
| Heartflow, INC. | $106.96 | 2019-2022 | |
| Amgen INC. | $76.16 | 2019-2022 | |
| Pfizer INC. | $40.83 | 2023 | |
| Novartis Pharmaceuticals Corporation | $33.96 | 2020-2022 | |
| Catalyst Pharmaceuticals, INC. | $29.30 | 2019 | |
| Amarin Pharma, INC. | $21.69 | 2019 | |
| Cardiva Medical, INC. | $20.01 | 2022 | |
| Elutia, INC. | $18.30 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $15.68 | 2020 | |
| Biosense Webster, INC. | $15.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alireza Nazeri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.